Showing posts with label institutional ownership. Show all posts
Showing posts with label institutional ownership. Show all posts
Friday, June 27, 2025

When the tech "hits the fan" so to speak, who might bid for Cabaletta Bio and their cutting edge technology?

›
  Cabaletta Bio is a compelling acquisition target  in a growing niche— cell therapy for autoimmune diseases . Its unique platform, strong e...
Sunday, January 5, 2025

IBM is an old dog, with some serious and cutting edge, new tricks in Ai and Quantum technology for 2025 - We-re adding!

›
  IBM Business and Investment Report: 2025 Introduction IBM (International Business Machines Corporation) is a global technology leader with...
Friday, September 6, 2024

Evolv Technology was instrumental in enhancing security during the 2024 Olympics with its AI-powered Evolv Express® systems, which provided non-intrusive, real-time weapons detection across high-traffic areas like entry points and public venues.

›
   As of 2024, Evolv holds over 200 patents and patent applications, with a focus on technologies that use AI and machine learning to enhanc...
Wednesday, July 10, 2024

Two years ago! That was the last time you could buy shares of Recursion Pharmaceuticals (NASDAQ: RXRX) at today's price! Here's why!

›
  Recursion Pharmaceuticals (NASDAQ: RXRX)   recently raised approximately $200 million through a public offering of 30,769,230 shares of it...
Tuesday, June 25, 2024

Going forward, how viable is Beam Therapeutics in the BioTech market?

›
  Fr: ChatGPT Beam Therapeutics appears to be a viable biotechnology company, with several strengths that contribute to its potential: Finan...